Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies might mistakenly attack healthy cells.

Related Keywords

Megan Craig , Dinler Antunes , Andref Fonseca , Nuclear Receptors , University Of Houston , Computational Biology , Assistant Professor , Immunotherapy , Dancer , Fell , Cell Signaling , Genes , Enetic , Heart , Mmunology , Melanoma , Protein , T Cell ,